<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-03T21:11:58Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/7277" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/7277</identifier><datestamp>2025-10-24T08:28:35Z</datestamp><setSpec>com_2072_451660</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_451662</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Are continued policies of prioritizing native vascular access in patients on hemodialysis programs useful?</dc:title>
   <dc:creator>Ibáñez Pallarès, Sara</dc:creator>
   <dc:creator>Velescu, Alina</dc:creator>
   <dc:creator>Tapia González, Irati</dc:creator>
   <dc:creator>Collado Nieto, Silvia</dc:creator>
   <dc:creator>Clara Velasco, Albert</dc:creator>
   <dc:creator>Esteve Simó, Vicent</dc:creator>
   <dc:contributor>[Ibáñez Pallarès S] Vascular Surgery Department, Hospital de Terrassa, Barcelona, Spain. Surgery and Morphologic Sciences Department, Autonomous University of Barcelona (UAB), Barcelona, Spain. [Esteve Simó V] Nephrology Department, Hospital de Terrassa, Barcelona, Spain. [Velescu A, Clara Velasco A] Vascular Surgery Department, Hospital del Mar, Barcelona, Spain. [Tapia González I] Nephrology Department, Hospital de Terrassa, Barcelona, Spain. Medicine Department, Autonomous University of Barcelona, Barcelona, Spain. [Collado Nieto S] Nephrology Department, Hospital del Mar, Barcelona, Spain</dc:contributor>
   <dc:contributor>Consorci Sanitari de Terrassa</dc:contributor>
   <dc:subject>Artèries</dc:subject>
   <dc:subject>Venes</dc:subject>
   <dc:subject>Dialisi</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Anastomosis, Surgical::Arteriovenous Shunt, Surgical</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Renal Replacement Therapy::Renal Dialysis</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Epidemiologic Studies::Case-Control Studies::Retrospective Studies</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::anastomosis quirúrgica::anastomosis quirúrgica arteriovenosa</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento de reemplazo renal::diálisis renal</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios epidemiológicos::estudios de casos y controles::estudios retrospectivos</dc:subject>
   <dc:description>AV access; dialysis; Native vascular access; Survival</dc:description>
   <dc:description>Acceso AV; diálisis; Acceso vascular nativo; Supervivencia</dc:description>
   <dc:description>Accés AV; Diàlisi; Accés vascular natiu; Supervivència</dc:description>
   <dc:description>The guidelines recommend establishing native vascular access as opposed to prosthetic or catheter-based access despite information relating to its effectiveness being scarce from a patient-orientated perspective. We analyzed the effectiveness of a continued policy of native vascular access (CPNVA) in patients undergoing hemodialysis. A retrospective, observational study, including 150 patients undergoing hemodialysis between 2006 and 2012 at our center, and who underwent a CPNVA. Statistical analysis was based on treatment intention. In 138 patients (92%), the first useful access (FUA) was native, and in 12 patients (8%), it was prosthetic. In 50 patients (33.3%), more than one procedure had to be carried out in to order to achieve FUA. The probability of dialysis occurring via a FUA was 67.1% and 45.3% at 1 and 5 years respectively. Over the follow-up period (mean time = 30 months), 84 patients (56%) required repairs or new access, extending the effectiveness of the CPNVA to 88.3% and 73.2% at 1 and 5 years respectively. The effectiveness of the CPNVA was reduced if the patient: required a catheter initially (HR: 3.6, p = 0.007); in cases of initially elevated glomerular filtration rate (HR: 1.1, p = 0.040); in cases of history of previous access failure before FUA (HR: 3.9, p = 0.001); and in female patients (HR: 2.4, p = 0.031). The long-term effectiveness of a CPNVA is high. However, the percentage of patients requiring diverse procedures in order to achieve FUA and the need for re-interventions yield the necessity to optimize preoperative evaluation and postoperative follow-up.</dc:description>
   <dc:date>2022-03-30T12:12:41Z</dc:date>
   <dc:date>2022-03-30T12:12:41Z</dc:date>
   <dc:date>2022-04</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Ibáñez Pallarès S, Esteve Simó V, Velescu A, Tapia González I, Collado Nieto S, Clara Velasco A. Are continued policies of prioritizing native vascular access in patients on hemodialysis programs useful? Ther Apher Dial. 2022 Apr;26(2):434-440.</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/7277</dc:identifier>
   <dc:identifier>10.1111/1744-9987.13711</dc:identifier>
   <dc:identifier>34296527</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/7277</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Therapeutic Apheresis and Dialysis;26(2)</dc:relation>
   <dc:relation>https://doi.org/10.1111/1744-9987.13711</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Wiley</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>